Epidemiology of juvenile myoclonic epilepsy

Por O. S. Shilkina, N. A. Schnaider
Publicado em 2017-06-01

PARP INHIBITORS IN OVARIAN CANCER: TOXICITY PROFILE

Por S. V. KHOKHLOVA, O. A. SHILKINA
Publicado em 2017-06-01

Juvenile myoclonic epilepsy: neurophysiological aspects

Por O. S. Shilkina, N. A. Shnaider, D. V. Dmitrenko, K. T. Kim
Publicado em 2018-07-01

Association of the carriage of <i>BRD2</i> rs206787 and rs516535 and <i>GJD2</i> rs3743123 polymorphisms with juvenile myoclonic epilepsy in Caucasian patients of Siberia

Por O. S. Shilkina, N. A. Shnayder, S. N. Zobova, D. V. Dmitrenko, P. V. Moskaleva
Publicado em 2019-12-01

Association of carriers of single nucleotide polymorphisms rs206787 and rs516535 in gene BRD2 and rs3743123 in gene GJD2 with juvenile myoclonic epilepsy of Caucasian patients in t...

Por O. S. Shilkina, N. A. Shnayder, S. N. Zobova, D. V. Dmitrenko, P. V. Moskaleva
Publicado em 2020-09-01

Problems of differential diagnosis of myoclon us-epilepsy associated with the mutation of the POLG gene and juvenile myoclonic epilepsy: a clinical case

Por O. S. Shilkina, N. A. Shnayder, I. P. Artyukhov, P. V. Moskaleva, Yu. S. Panina
Publicado em 2018-04-01

CLINICAL AND GENETIC HETEROGENITY OF JUVENILE MYOCLONIC EPILEPSY

Por N. A. Shnayder, O. S. Shilkina, K. V. Petrov, I. A. Chernykh, A. V. Diuzhakova
Publicado em 2016-08-01

FREQUENCY OF CLINICAL PHENOTYPES OF JUVENILE MYOCLONIC EPILEPSY: PILOT STUDY IN SIBERIAN FEDERAL DISTRICT

Por N. A. Shnayder, O. S. Shilkina, K. V. Petrov, A. V. Duyzhakova, N. A. Marueva
Publicado em 2016-12-01